Skip to content

A pilot clinical trial of introduction and adjustment algorithm of insulin degludec in hospitalized patients with type 2 diabetes.

A pilot clinical trial of introduction and adjustment algorithm of insulin degludec in hospitalized patients with type 2 diabetes. - I-deg trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000037642
Enrollment
30
Registered
2019-08-09
Start date
2019-03-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

None listed

Sponsors

Department of Diabetes and Endocrinology, Kansai Rosai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: hospitalized type2 diabetes patients at 2017/9-2018/3

Exclusion criteria

Exclusion criteria: a) The patient who became the hospitalization for an unexpected reason except the insulin adjustment. The patient who other diseases including the b) malignant tumor were found out, and came to cannot but extend length of stay c) Type I diabetes mellitus patient d) The patient whom a factor to affect the blood sugar level including the steroid medicine clearly produced e) The patient who does not adjust it using algorithm

Design outcomes

Primary

MeasureTime frame
The number of days required to achieve a fasting blood glucose level of 130 mg/dl or less, hospitalization, hypoglycemia

Countries

Japan

Contacts

Public ContactShuhei Nishina

Kansai Rosai Hospital Department of Diabetes and Endocrinology

shuhee247@yahoo.co.jp06-6416-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026